Our story
The front door to environmental health.
MoldCo exists because mold-related illness is too often split into disconnected pieces: a building problem over here, a symptom problem over there, and no clear next step between them.
Why MoldCo
A clearer path through a messy category.
MoldCo was built for people who have credible exposure, persistent symptoms, and no coordinated way to understand whether the body, the home, or both need attention.
The category is confusing because several things get collapsed into one word: visible mold, damp-building exposure, allergies, mycotoxins, inflammatory response, and CIRS-informed care.
MoldCo's job is to keep those lanes separate while giving patients a usable next step. The marketing site educates. The app handles patient records, checkout, messaging, and care.
Meet your providers
Clinical judgment stays in the room.
MoldCo care is led by licensed providers with MoldCo training and clinical direction. Public content is reviewed for claim clarity and medical boundaries.
Dr. Scott McMahon
Medical Director
Clinical oversight for MoldCo's care approach, biomarker framing, and evidence boundaries.
Ariana Thacker
Founder and CEO
Founder perspective on access, affordability, and the patient experience that led to MoldCo.
Jane Prescot
Environmental health reviewer
Environmental health review support for patient education, source-control language, and claim calibration.
For partners
A cleaner handoff for patients who may need both lanes.
Inspectors, remediators, and clinicians should not have to overstep scope to help someone find the next step.
Providers
MoldCo can complement primary care, functional medicine, and specialty care by handling the mold-related illness pathway it is built for.
Inspectors and remediators
Building professionals solve the source-control problem. MoldCo gives clients a body-side care path without asking partners to give medical advice.
Referral conversations
Partner language should avoid guarantees, diagnosis claims, and treatment advice. The handoff is: this may be worth clinical evaluation.